Advertisement
HANNOVER MESSE 2018, 23 - 27 April
R&D-Project

ULTRAPLACAD

ULTRAsensitive PLAsmonic devices for early CAncer Diagnosis

Scriba Nanotecnologie

Exhibitor details
Logo ULTRAPLACAD
Logo ULTRAPLACAD
Logo ULTRAPLACAD
Logo ULTRAPLACAD

Exhibition stand
(Main stand)

Hall 2, Stand B61/2

Product description

ULTRAPLACAD project represents a radical change in colorectal cancer early diagnostics and therapy monitoring, finally reaching the detection of circulating biomarkers in blood (liquid biopsy). The diagnostic test market is expected to reach 670M$ in 2020. The market of Colorectal Cancer diagnostics (CRC) should reach 74M$ in 2020.
Cancer biomarkers, in particular DNA, mRNA and tumour antibodies, circulating in body fluids, have been shown to reflect the pathological process. For this reason, they can be used for cancer diagnosis, prognosis and choice for therapeutic interventions. Biomarker detection is a key aspect to new minimally-invasive diagnostic approaches.
ULTRAPLACAD aims at the development of a novel robust in vitro diagnostic system for early cancer diagnosis, based on molecular analysis of peripheral blood (liquid biopsy).
The project is focused at developing a compact plasmonic-based disposable device with an integrated microfluidic circuit and functionalized nanostructures for the detection of DNA, microRNA and tumor autoantibodies. The aim is to detect these cancer biomarkers circulating in blood with improvement in sensitivity, reduction in cost of platform compared to today s available techniques and analysis time less than 1h.

Development status
Under development

Market introduction
03.2021

Degree of documentation
Well documented

Market orientation
Medium-size market

Product website

All products offered by this exhibitor

Nu-CODE(TM)

Miniaturized data-matrixesread more

Mold and replicas services

Scriba can fabricate rigid molds and flexible replicas designed according to our customer s specification. We can add personalized details of micro and sub-micrometric scale. The molds we produce are generally used for flexographic printing of inks, solutions and formulations, for fabrication of composite ...read more

Microfluidic devices

Our strengths are the complete customization of our systemsread more

Microelectrodes and Patternig

Scriba has developed an innovative fabrication method of gold, silver and platinum microelectrodes. They can be fabricated on different substrates, rigid, like quartz and glass or flexible, like PET and PEN. Scriba s microelectrodes can be easily fabricated with different parameters of width (W) and ...read more

Field Effect Transistor EGOFET

Novel tools for Organic Bio-Electronicsread more

R&D-Project

MADIA

MAgnetic DIagnostic Assay for neurodegenerative diseasesread more

R&D-Project

ULTRAPLACAD

ULTRAsensitive PLAsmonic devices for early CAncer Diagnosisread more

R&D-Project

iSWITCH

Integrated self-assembled Switchable systems and materialsread more

Stored items

0

Server communication error: Item could not be saved.